HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supply Of 'Important' OTCs From EU Prioritized In Event Of No Deal Brexit

Executive Summary

In preparation for a possible no deal Brexit, the UK government is prioritizing supply from the EU those OTC medicines deemed "important for the management of specific health conditions." The Department of Health and Social Care says it is continuing to work closely with OTC manufacturers and suppliers to prepare for Brexit.
Advertisement

Related Content

UK Plan To Replace EFSA Post-Brexit Leaves Industry With Unanswered Questions
Supplement Firms Face Spiralling Costs And Serious Disruption In Event Of No Deal Brexit
UK To Overhaul Health Claims Approval In Event of 'No Deal' Brexit
European Trade Groups To Cosmetics Firms: Be Prepared For ‘No Deal’ Brexit
MHRA consulting for ‘no deal’ Brexit

Topics

Advertisement
UsernamePublicRestriction

Register

RS148573

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel